I agree that it will be sold at bargain basement prices, IF, it is to be utilised as a one and done treat to catch all infections.
I have a feeling it will be slightly more expensive and turn enough of a profit to sustain further trials and, that’s about it.
Hypothetically, lets say it’s utilisation cost will be 5x traditional drugs, although it’s expensive to the developing world. its initial expense is insignificant to the reduction in GDP contribution one whole person could lose with amputation.
im not saying it will be used, rather it may be considered as a far more as an economic impact more so than immediate financial impact to healthcare.
if you dig through all RCE announcements, you will come to the same conclusion I have on what it actually costs to produce. 327, costs peanuts, the gel component is the unknown in my equation….but surely it wouldn’t be sky high…..
RCE Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)